ANSTO is the new production partner of OncoBeta® GmbH in Australia
Innovative medical device Rhenium-SCT® therapy for non-melanoma skin cancer is now available in Australia
Showing 901 - 920 of 1319 results
Innovative medical device Rhenium-SCT® therapy for non-melanoma skin cancer is now available in Australia
Combining scientific expertise with more than $1.3 billion in unique operational assets to provide optimal radioactive waste solutions.
Oleh Nakone has over 20 years’ experience in Executive Leadership roles within the Pharmaceutical and Health Care Industries.
Creating a safe, inclusive and respectful online community for all.
Monash University researchers have used advanced techniques at ANSTO to investigate the production of new, elongated polymer nanocapsules with a high payload of drug nanocrystals to potentially increase drug targetability, and also decrease dosage frequency and side effects.
Come and discover the world of nuclear science at ANSTO - book a school tour in Sydney today.
You are invited to submit to the various awards from ANSTO, User Advisory Committee (UAC) and Australian Neutron Beam User Group (ANBUG).
You are invited to submit to the various awards from ANSTO and the User Meeting 2024 organising committee.
You are invited to submit to the various awards from ANSTO and the User Meeting 2025 organising committee.
COVID-19 is being investigated thanks to our world-class infrastructure, researchers and scientists.